NCT04642820View on ClinicalTrials.gov

Drugs Brain and Behavior (DDP)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

October 1, 2023

Study Completion Date

June 1, 2024

Conditions
Stimulant Use
Interventions
DRUG

Methamphetamine

Participants will be given 20 mg of Methamphetamine.

DRUG

placebo oral tablet

Participants will be given a placebo capsule that will only contain lactose.

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Chicago

OTHER

NCT04642820 - Drugs Brain and Behavior (DDP) | Biotech Hunter | Biotech Hunter